Education
About Us
Working with TipRanks
Follow Us
Oaktree Acquisition Corp. III Life Sciences Class A (OACC)
NASDAQ:OACC
Total Valuation
Oaktree Acquisition Corp. III Life Sciences Class A has a market cap or net worth of $44.65M. The enterprise value is ―.
Market Cap$44.65M
Enterprise Value―
Share Statistics
Oaktree Acquisition Corp. III Life Sciences Class A has 19,783,010 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding19,783,010
Owned by Insiders―
Owned by Institutions52.43%
Financial Efficiency
Oaktree Acquisition Corp. III Life Sciences Class A’s return on equity (ROE) is <0.01 and return on invested capital (ROIC) is >-0.01%.
Return on Equity (ROE)<0.01
Return on Assets (ROA)<0.01
Return on Invested Capital (ROIC)>-0.01%
Return on Capital Employed (ROCE)>-0.01
Revenue Per Employee―
Profits Per Employee―
Employee Count―
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Oaktree Acquisition Corp. III Life Sciences Class A is 42.92. Oaktree Acquisition Corp. III Life Sciences Class A’s PEG ratio is ―.
PE Ratio42.92
PS Ratio0.00
PB Ratio-10.10K
Price to Fair Value<0.01
Price to FCF-2.77K
Price to Operating Cash Flow-2.60K
PEG Ratio―
Income Statement
In the last 12 months, Oaktree Acquisition Corp. III Life Sciences Class A had revenue of 0.00 and earned ― in profits. Earnings per share was 0.23.
Revenue0.00
Gross Profit0.00
Operating Income―
Pretax Income―
Net Income―
EBITDA0.00
Earnings Per Share (EPS)0.23
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Oaktree Acquisition Corp. III Life Sciences Class A pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.08
52-Week Price Change5.83%
50-Day Moving Average10.32
200-Day Moving Average―
Relative Strength Index (RSI)70.49
Average Volume (3m)133.43K
Important Dates
Oaktree Acquisition Corp. III Life Sciences Class A upcoming earnings date is ―, TBA Not Confirmed.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Oaktree Acquisition Corp. III Life Sciences Class A as a current ratio of 2.14, with Debt / Equity ratio of -473.72%
Current Ratio2.14
Quick Ratio2.14
Debt to Market Cap0.10
Net Debt to EBITDA0.00
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Oaktree Acquisition Corp. III Life Sciences Class A has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Oaktree Acquisition Corp. III Life Sciences Class A EV to EBITDA ratio is 0.00, with an EV/FCF ratio of 6.86K.
EV to Sales0.00
EV to EBITDA0.00
EV to Free Cash Flow6.86K
EV to Operating Cash Flow6.86K
Balance Sheet
Oaktree Acquisition Corp. III Life Sciences Class A has $0.00 in cash and marketable securities with $109.41K in debt, giving a net cash position of $109.41K billion.
Cash & Marketable Securities$0.00
Total Debt$109.41K
Net Cash$109.41K
Net Cash Per Share<$0.01
Tangible Book Value Per Share$16.34K
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Oaktree Acquisition Corp. III Life Sciences Class A is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―